Knapke CM, Owens JP, Mirtallo JM: Management of glucose abnormalities in patients receiving total parenteral nutrition. Clin Pharm Vol 8:136-144, 1989
2.
Goldman J., Baldwin D., Rubinstein AH, et al: Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia. J Clin Invest63:1050, 1979
3.
Taylor SI, Grunberger G., Marcus-Samuels B., et al: Hypoglycemia associated with antibodies to the insulin receptor . N Engl J Med307:1422, 1982
4.
Arky RA: Antibodies and disorders of glucose metabolism: A courting couple (letter) . N Engl J Med307:1445, 1982
Hadju-Georgopoulos A., Schmidt MI, Margolis S., et al: Elevated hypoglycemic index and late hyperinsulinism in symptomatic postprandial hypoglycemia. J Clin Endocrinol Metab50:371, 1980
7.
Levi-Ran A., Anderson RW: The diagnosis of postprandial hypoglycemia. Diabetes30:996, 1981
8.
Kahn CR, Shechter Y.: Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas , in Goodman, Rail, Nies, et al (eds) in Goodman and Gilman, The Pharmacological Basis of Therapeutics , eighth ed. New York, NY, Pergamon Press, 1990
9.
DCCT Research Group: Are continuing studies of metabolic and microvascular complications in insulin dependent diabetes mellitus justified? N Engl J Med318:246-247, 1988
10.
Gilman AG, Rail TW, Nies AS, et al: Metabolic and Nutritional Diseases of the Nervous System, in Wintrobe MM, Thorn GW, Adams RD, et al (eds): Harrison's Principles of Internal Medicine, seventh ed. McGraw-Hill Book Company, New York, NY, 1974
11.
Kalimo H., Olsson Y.: Effects of severe hypoglycemia on the human brain. Neuropathological case reports. Act Neurol Scand62:345-356, 1980
12.
Lindvall O. , Auer RN, Siesjo BK: Mechanisms of hypoglycemic brain damage. Exp Brain Res73:219-223, 1988
13.
Hepburn DA, Steel JM, Frier BM: Hypoglycemic convulsions cause serious musculoskeletal injuries in patients with IDDM. Diabetes Care12:32-34, 1990
14.
Blackman JD , Towle VL, Lewis GF, et al: Hypoglycemic thresholds for cognitive dysfunction in humans. Diabetes39:828-835, 1990
15.
Cahill GF: Scientific American Medicine. 9 Metab; 1 Hypoglycemia-2: 1987
16.
Clarke WL, Gonder-Frederick LA, Richards FE, et al: Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Diabetes40:680-685, 1991
17.
Teuscher A. , Berger WG: Hypoglycemia unawareness in diabetics transferred from beef/porcine insulin to human insulin. Lancet382-385, 1987
18.
Position Statement : Insulin Administration. Diabetes Care14:30, 1991 (suppl 2)
19.
Jick SS, Derby LE, Gross KM, et al: Hospitalizations because of hypoglycemia in users of animal and human insulin. 2. Experience in the United States. Pharmacotherapy10:398-399, 1990
20.
Cryer PE: Glucose counterregulation in man (review). Diabetes30:261, 1981
21.
DeFronzo RA , Hendler R., Christensen N.: Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration. Diabetes29:125, 1980
22.
O'Donnell JT : Pharmacist error suggested in baby's brain damage. Drug Topic Hospital Pharmacy Report Sept 1991, p 1, 26-27 (suppl)
23.
Peterson vs Fairfax hospital et al, Fairfax County Va 111888
24.
O'Donnell JT : $60 million in damages sought in insulin cover-up suit. Drug Topics Hospital Pharmacy Report April, 1992, 1,8 (suppl)
25.
Gebhart F.: Test Hyperal Solutions? Fla. mom says Yes. Drug Topics Hospital Pharmacy Report February, 1992, p 35 (Suppl)
26.
Davis NM: Unprecedented procedural safeguards needed with the use of automated IV compounders . Hosp Pharm27:488, 1992 (editorial)
27.
Meyer GE, Novelli KA, Smith JE: Use of a refractive index measurement for quality assurance of pediatric parenteral nutrient solutions. Am J Hosp Pharm44:1617-1620, 1987
28.
Edmondson vs Severino et al: 83 L 1452, Cook County Illinois
29.
AMA Drug Evaluations, 6th Edition. American Medical Association, 1986
30.
Drug Evaluations Annual1992, Parenteral and Enteral Nutrition Chapter Update. American Medical Association, Chicago, IL, 1990, p 2045
31.
Lamer J.: Insulin and oral hypoglycemic drugs; glucagon, in Gilman AG, Goodman LS, Rall TW, Murad F (eds): in Goodman and Gilman's The Pharmacologic Basis of Therapeutics , seventh ed. New York, NY, Macmillan , 1985, p 1502
32.
Handbook of Nonprescription Drugs, 7th Ed. American Pharmaceutical Association, Washington, DC
33.
Birkinshaw VJ, Gurd MR, Randall SS, et al: Investigations in increase of murder by insulin poisoning. Br Med J August 23:463-468, 1958
34.
Polson CJ, Green MA, Lee MR: Insulin and other agents that lower blood sugar, in Clinical Toxicology, 3rd ed. Philadelphia, PA, JB Lippincott, 1983, p 343
35.
Stofer AR: Suicid mit Insulin und Nachweis des Insulin and der Leiche. Arch Toxikol26:1-7,1970
36.
Sturner WG, Putnam RS: Suicidal insulin poisoning with nine day survival: Recovery in Bile at autopsy by radioimmunoassay. J Forensic Sci17:514-521, 1972
37.
Dickson SJ, Cairns ER, Blazey ND: The isolation and quantitation of insulin in post-mortem specimens—a case report. Forensic Sci9:37-42,1977
38.
Loubatieres A. : History and development of the oral hypoglycemic agents, in Campbell GD (ed): Oral Hypoglycemic Agents. London, Academic Press, 1969
39.
Ferner RE: Oral hypoglycemic agents. Med Clin North Am72:1323, 1988
40.
Campbell IW : Metformin and the sulfonylureas: Comparative risks. Horm Metab Res15:105-111, 1985 (suppl)
41.
Dahlen M., Bergman U., Idman L., et al: Epidemiology of hypoglycemia on oral antidiabetic drugs in the island of Gotlan, Sweden. Acta Endocrinol263:21, 1984 (Suppl) 42. Asplund K., Wilholm B-E., Lithner F.: Glibenclamide-associated hypoglycemia: A report of 57 cases. Diabetologia24:412-417, 1983
42.
Ferner RE, Neil Haw: Sulphonylureas and hypoglycemia. Br Med J296:949-950, 1988
43.
Krall LP, Chabot VA: Oral hypoglycemic agent update. Med Clin North Am62:681-694,1978
44.
Marigo S., Cavallini ET, Beltrami M., Sidnorelli F.: Tenato Suicidio Con glibenclamide. Acta Diabet Lat9:688-696, 1972
